rs1008328

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001083961.2(WDR62):​c.4170A>C​(p.Leu1390Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.761 in 1,613,644 control chromosomes in the GnomAD database, including 469,035 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 42774 hom., cov: 32)
Exomes 𝑓: 0.76 ( 426261 hom. )

Consequence

WDR62
NM_001083961.2 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: -0.126

Publications

36 publications found
Variant links:
Genes affected
WDR62 (HGNC:24502): (WD repeat domain 62) This gene is proposed to play a role in cerebral cortical development. Mutations in this gene have been associated with microencephaly, cortical malformations, and cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2011]
WDR62 Gene-Disease associations (from GenCC):
  • microcephaly 2, primary, autosomal recessive, with or without cortical malformations
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics, Illumina, G2P, ClinGen
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.692469E-7).
BP6
Variant 19-36104534-A-C is Benign according to our data. Variant chr19-36104534-A-C is described in ClinVar as [Benign]. Clinvar id is 160301.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.774 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WDR62NM_001083961.2 linkc.4170A>C p.Leu1390Phe missense_variant Exon 31 of 32 ENST00000401500.7 NP_001077430.1 O43379-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WDR62ENST00000401500.7 linkc.4170A>C p.Leu1390Phe missense_variant Exon 31 of 32 1 NM_001083961.2 ENSP00000384792.1 O43379-4

Frequencies

GnomAD3 genomes
AF:
0.749
AC:
113841
AN:
151982
Hom.:
42761
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.700
Gnomad AMI
AF:
0.616
Gnomad AMR
AF:
0.786
Gnomad ASJ
AF:
0.759
Gnomad EAS
AF:
0.747
Gnomad SAS
AF:
0.599
Gnomad FIN
AF:
0.782
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.777
Gnomad OTH
AF:
0.759
GnomAD2 exomes
AF:
0.750
AC:
188442
AN:
251128
AF XY:
0.745
show subpopulations
Gnomad AFR exome
AF:
0.698
Gnomad AMR exome
AF:
0.807
Gnomad ASJ exome
AF:
0.760
Gnomad EAS exome
AF:
0.750
Gnomad FIN exome
AF:
0.770
Gnomad NFE exome
AF:
0.774
Gnomad OTH exome
AF:
0.764
GnomAD4 exome
AF:
0.762
AC:
1114342
AN:
1461544
Hom.:
426261
Cov.:
76
AF XY:
0.759
AC XY:
551863
AN XY:
727086
show subpopulations
African (AFR)
AF:
0.700
AC:
23442
AN:
33480
American (AMR)
AF:
0.806
AC:
36060
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.752
AC:
19654
AN:
26128
East Asian (EAS)
AF:
0.769
AC:
30525
AN:
39700
South Asian (SAS)
AF:
0.617
AC:
53253
AN:
86254
European-Finnish (FIN)
AF:
0.775
AC:
41177
AN:
53152
Middle Eastern (MID)
AF:
0.757
AC:
4366
AN:
5768
European-Non Finnish (NFE)
AF:
0.774
AC:
860623
AN:
1111958
Other (OTH)
AF:
0.749
AC:
45242
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
17423
34846
52268
69691
87114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20494
40988
61482
81976
102470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.749
AC:
113895
AN:
152100
Hom.:
42774
Cov.:
32
AF XY:
0.748
AC XY:
55623
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.699
AC:
28992
AN:
41464
American (AMR)
AF:
0.786
AC:
12017
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.759
AC:
2634
AN:
3470
East Asian (EAS)
AF:
0.746
AC:
3844
AN:
5152
South Asian (SAS)
AF:
0.599
AC:
2889
AN:
4822
European-Finnish (FIN)
AF:
0.782
AC:
8286
AN:
10594
Middle Eastern (MID)
AF:
0.786
AC:
231
AN:
294
European-Non Finnish (NFE)
AF:
0.777
AC:
52842
AN:
67994
Other (OTH)
AF:
0.757
AC:
1601
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1488
2975
4463
5950
7438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
852
1704
2556
3408
4260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.768
Hom.:
117215
Bravo
AF:
0.751
TwinsUK
AF:
0.770
AC:
2854
ALSPAC
AF:
0.769
AC:
2965
ESP6500AA
AF:
0.696
AC:
3066
ESP6500EA
AF:
0.776
AC:
6676
ExAC
AF:
0.742
AC:
90139
Asia WGS
AF:
0.636
AC:
2212
AN:
3478
EpiCase
AF:
0.782
EpiControl
AF:
0.785

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 24, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Benign:4
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:4
Jun 05, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
4.3
DANN
Benign
0.54
DEOGEN2
Benign
0.00089
.;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.0017
N
LIST_S2
Benign
0.083
T;T
MetaRNN
Benign
9.7e-7
T;T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-0.34
.;N
PhyloP100
-0.13
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.38
N;N
REVEL
Benign
0.055
Sift
Benign
0.31
T;T
Sift4G
Benign
0.56
T;T
Polyphen
0.0020
B;B
Vest4
0.029
MutPred
0.36
.;Loss of phosphorylation at S1388 (P = 0.1262);
MPC
0.24
ClinPred
0.0034
T
GERP RS
2.0
Varity_R
0.047
gMVP
0.045
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1008328; hg19: chr19-36595436; COSMIC: COSV54335267; API